The European Association for Cancer Research (EACR) conference, "Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy," is a Virtual Event scheduled for January 20-21, 2026. This conference explores a paradoxical and radically different approach to cancer therapy: instead of inhibiting the signals that drive cancer, it focuses on the deliberate hyper-activation of oncogenic […]
The European Association for Cancer Research (EACR) conference, "Signalling Circuits in Cancer," is a Virtual Event scheduled for February 10–11, 2026. This event will focus on the fundamental mechanisms that control cancer cell signalling circuits and how they govern cancer progression and resistance to therapy. The conference will highlight how therapy resistance is often initiated […]
The Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond is the European Association for Cancer Research’s (EACR) inaugural virtual conference on this topic, scheduled for February 24–25, 2026. The two-day virtual summit is dedicated to showcasing cutting-edge developments in immunotherapy, spanning from basic research to clinical applications, with a strong emphasis on […]
The Data-Driven Cancer Research Conference is a comprehensive three-day scientific event hosted by Cancer Research UK in partnership with the EACR (European Association for Cancer Research), scheduled for February 24–26, 2026. Set in the historic city of Edinburgh, the conference explores the intersection of data science and oncology, featuring expert-led discussions on AI-accelerated early detection, […]
The EACR conference on The Tumour Ecosystem: From Mechanisms to Novel Therapeutics will be held from 17 to 19 March 2026 in Bergamo, Italy. Organized by the European Association for Cancer Research (EACR), the event's venue is the Centro Congressi Giovanni XXIII. The conference will focus on the latest research in the tumor microenvironment, covering how cancer […]
The Cancer Genomics, Multiomics and Computational Biology conference, organized by the European Association for Cancer Research (EACR), will take place in Essen, Germany, from May 12-14, 2026. This 7th edition of the conference will showcase the latest breakthroughs in cancer genomics, multiomics, and computational biology. The cutting-edge program will cover topics such as machine learning […]
The EACR 2026 Congress: Innovative Cancer Science is the Annual Congress of the European Association for Cancer Research (EACR). This four-day congress, dedicated to basic, preclinical, and translational cancer research, will take place from June 8-11, 2026, in Budapest, Hungary. The congress is designed to showcase the latest research, highlight a wide breadth of topics, […]
The 3rd International CAM Conference (CAMCON 2026): modelling diseases, regeneration, molecular mechanisms and therapy is a specialized scientific event dedicated to the use of the Chorioallantoic Membrane (CAM) model—an alternative in vivo model derived from chicken embryos. Scheduled for June 30 – July 2, 2026, in Liverpool, UK, the conference addresses technical advancements in oncology, […]
The European Association for Cancer Research (EACR) conference, "Liquid Biopsies 2026," will take place in Lyon, France, from September 22–24, 2026. This conference will gather world-leading experts to explore the latest advances in circulating nucleic acids, circulating tumour cells (CTCs), and extracellular vesicles (EVs) across the entire cancer continuum. The educational program is structured into four […]
The European Association for Cancer Research (EACR) Conference on Cancer Metabolism will be held in Bilbao, Spain, from October 6–8, 2026. This conference focuses on metabolic reprogramming, a key hallmark of tumors, and the metabolic alterations that cancer and stromal cells undergo to meet energetic demands, survive in hostile environments, and modify their niche. The […]
The European Association for Cancer Research (EACR) conference, "Chromosomes in Crisis: From Chromosomal Instability to Catastrophes in Cancer Genomes," will take place in Berlin, Germany, from November 3–5, 2026. The conference will bring together experts to explore the mechanisms, consequences, and therapeutic vulnerabilities associated with large-scale genomic rearrangements in cancer. The educational focus is on […]